US Stock MarketDetailed Quotes

INmune Bio (INMB)

Watchlist
  • 1.630
  • -0.070-4.12%
Trading Jan 23 13:28 ET
43.33MMarket Cap-0.78P/E (TTM)

INmune Bio (INMB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.14%-5.44M
6.48%-7.38M
8.72%-6.82M
-178.47%-33.36M
-223.82%-11.01M
-63.84%-6.99M
-148.46%-7.89M
-555.21%-7.48M
47.19%-11.98M
40.28%-3.4M
Net income from continuing operations
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
Other non cash items
----
----
----
-64.73%79K
-86.67%6K
-72.22%15K
-58.62%24K
-49.25%34K
-6.28%224K
-33.82%45K
Change In working capital
-140.11%-1.35M
-87.74%-965K
-51.67%839K
-90.06%1.04M
-215.41%-3.56M
43.17%3.37M
-136.56%-514K
-51.66%1.74M
464.39%10.44M
279.45%3.08M
-Change in receivables
-115.50%-309K
-2.21%-739K
97.18%-7K
-82.84%1.03M
106.15%11K
1,018.43%1.99M
-540.85%-723K
-103.97%-248K
303.55%6.02M
95.45%-179K
-Change in prepaid assets
-75.37%33K
-350.42%-298K
-76.15%124K
-45.16%1.32M
568.38%548K
-88.85%134K
-87.22%119K
32.32%520K
236.18%2.41M
-117.70%-117K
-Change in payables and accrued expense
-126.88%-329K
680.28%554K
-47.88%737K
-163.20%-1.37M
-220.81%-4.08M
-14.88%1.22M
-82.07%71K
146.50%1.41M
23.84%2.17M
84.69%3.38M
-Change in other current assets
-17,500.00%-176K
-2,184.00%-521K
20.00%30K
262.50%52K
250.00%3K
-200.00%-1K
180.65%25K
--25K
---32K
---2K
-Change in other current liabilities
-1,120.00%-61K
214.29%8K
-33.33%-8K
-525.00%-25K
-170.00%-7K
-25.00%-5K
69.57%-7K
-146.15%-6K
87.88%-4K
108.62%10K
-Change in other working capital
-1,925.00%-511K
3,000.00%31K
-219.35%-37K
122.05%28K
-357.14%-32K
143.75%28K
103.23%1K
224.00%31K
-189.44%-127K
95.68%-7K
Cash from discontinued investing activities
Operating cash flow
22.14%-5.44M
6.48%-7.38M
8.72%-6.82M
-178.47%-33.36M
-223.82%-11.01M
-63.84%-6.99M
-148.46%-7.89M
-555.21%-7.48M
47.19%-11.98M
40.28%-3.4M
Investing cash flow
Cash flow from continuing investing activities
-193K
0
Net PPE purchase and sale
---193K
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---193K
----
----
----
----
--0
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
0
71.35%22.27M
310.96%5.27M
531.03%18.21M
16.88%-2.08M
667.65%9.79M
13M
-2.5M
-679.56%-4.23M
-2.5M
Net issuance payments of debt
--0
--0
--0
-100.00%-10M
0.00%-2.5M
0.00%-2.5M
---2.5M
---2.5M
---5M
---2.5M
Net common stock issuance
--0
43.71%22.27M
--5.27M
3,485.68%27.79M
--0
1,486.06%12.29M
--15.5M
--0
10.87%775K
--0
Proceeds from stock option exercised by employees
--0
--0
--1K
--422K
--422K
--0
--0
--0
--0
----
Cash from discontinued financing activities
Financing cash flow
--0
71.35%22.27M
310.96%5.27M
531.03%18.21M
16.88%-2.08M
667.65%9.79M
--13M
---2.5M
-679.56%-4.23M
---2.5M
Net cash flow
Beginning cash position
7.42%33.37M
-25.63%19.34M
-41.64%20.92M
-31.26%35.85M
-19.76%33.55M
-35.04%31.07M
-49.02%26M
-31.26%35.85M
-30.29%52.15M
-27.16%41.81M
Current changes in cash
-300.71%-5.63M
177.64%14.19M
84.46%-1.55M
6.51%-15.15M
-121.84%-13.09M
146.85%2.81M
261.03%5.11M
-774.32%-9.98M
26.20%-16.21M
-3.62%-5.9M
Effect of exchange rate changes
97.52%-8K
-247.73%-153K
-126.92%-35K
324.00%224K
820.31%461K
-1,304.35%-323K
-1,000.00%-44K
1,544.44%130K
85.71%-100K
-114.45%-64K
End cash Position
-17.34%27.73M
7.42%33.37M
-25.63%19.34M
-41.64%20.92M
-41.64%20.92M
-19.76%33.55M
-35.04%31.07M
-49.02%26M
-31.26%35.85M
-31.26%35.85M
Free cash flow
19.38%-5.63M
-2.47%-8.08M
8.72%-6.82M
-178.47%-33.36M
-223.82%-11.01M
-63.84%-6.99M
-148.46%-7.89M
-555.21%-7.48M
47.19%-11.98M
40.28%-3.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.14%-5.44M6.48%-7.38M8.72%-6.82M-178.47%-33.36M-223.82%-11.01M-63.84%-6.99M-148.46%-7.89M-555.21%-7.48M47.19%-11.98M40.28%-3.4M
Net income from continuing operations 46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M
Other non cash items -------------64.73%79K-86.67%6K-72.22%15K-58.62%24K-49.25%34K-6.28%224K-33.82%45K
Change In working capital -140.11%-1.35M-87.74%-965K-51.67%839K-90.06%1.04M-215.41%-3.56M43.17%3.37M-136.56%-514K-51.66%1.74M464.39%10.44M279.45%3.08M
-Change in receivables -115.50%-309K-2.21%-739K97.18%-7K-82.84%1.03M106.15%11K1,018.43%1.99M-540.85%-723K-103.97%-248K303.55%6.02M95.45%-179K
-Change in prepaid assets -75.37%33K-350.42%-298K-76.15%124K-45.16%1.32M568.38%548K-88.85%134K-87.22%119K32.32%520K236.18%2.41M-117.70%-117K
-Change in payables and accrued expense -126.88%-329K680.28%554K-47.88%737K-163.20%-1.37M-220.81%-4.08M-14.88%1.22M-82.07%71K146.50%1.41M23.84%2.17M84.69%3.38M
-Change in other current assets -17,500.00%-176K-2,184.00%-521K20.00%30K262.50%52K250.00%3K-200.00%-1K180.65%25K--25K---32K---2K
-Change in other current liabilities -1,120.00%-61K214.29%8K-33.33%-8K-525.00%-25K-170.00%-7K-25.00%-5K69.57%-7K-146.15%-6K87.88%-4K108.62%10K
-Change in other working capital -1,925.00%-511K3,000.00%31K-219.35%-37K122.05%28K-357.14%-32K143.75%28K103.23%1K224.00%31K-189.44%-127K95.68%-7K
Cash from discontinued investing activities
Operating cash flow 22.14%-5.44M6.48%-7.38M8.72%-6.82M-178.47%-33.36M-223.82%-11.01M-63.84%-6.99M-148.46%-7.89M-555.21%-7.48M47.19%-11.98M40.28%-3.4M
Investing cash flow
Cash flow from continuing investing activities -193K0
Net PPE purchase and sale ---193K------------------0----------------
Cash from discontinued investing activities
Investing cash flow ---193K------------------0----------------
Financing cash flow
Cash flow from continuing financing activities 071.35%22.27M310.96%5.27M531.03%18.21M16.88%-2.08M667.65%9.79M13M-2.5M-679.56%-4.23M-2.5M
Net issuance payments of debt --0--0--0-100.00%-10M0.00%-2.5M0.00%-2.5M---2.5M---2.5M---5M---2.5M
Net common stock issuance --043.71%22.27M--5.27M3,485.68%27.79M--01,486.06%12.29M--15.5M--010.87%775K--0
Proceeds from stock option exercised by employees --0--0--1K--422K--422K--0--0--0--0----
Cash from discontinued financing activities
Financing cash flow --071.35%22.27M310.96%5.27M531.03%18.21M16.88%-2.08M667.65%9.79M--13M---2.5M-679.56%-4.23M---2.5M
Net cash flow
Beginning cash position 7.42%33.37M-25.63%19.34M-41.64%20.92M-31.26%35.85M-19.76%33.55M-35.04%31.07M-49.02%26M-31.26%35.85M-30.29%52.15M-27.16%41.81M
Current changes in cash -300.71%-5.63M177.64%14.19M84.46%-1.55M6.51%-15.15M-121.84%-13.09M146.85%2.81M261.03%5.11M-774.32%-9.98M26.20%-16.21M-3.62%-5.9M
Effect of exchange rate changes 97.52%-8K-247.73%-153K-126.92%-35K324.00%224K820.31%461K-1,304.35%-323K-1,000.00%-44K1,544.44%130K85.71%-100K-114.45%-64K
End cash Position -17.34%27.73M7.42%33.37M-25.63%19.34M-41.64%20.92M-41.64%20.92M-19.76%33.55M-35.04%31.07M-49.02%26M-31.26%35.85M-31.26%35.85M
Free cash flow 19.38%-5.63M-2.47%-8.08M8.72%-6.82M-178.47%-33.36M-223.82%-11.01M-63.84%-6.99M-148.46%-7.89M-555.21%-7.48M47.19%-11.98M40.28%-3.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More